PharmaTimes

FDA panel to decide on Boostrix and Adacel vaccines

The US Food and Drug Administration appears comfortable with the safety and efficacy profiles presented in filings for GlaxoSmithKline and Sanofi Pasteur’s diphtheria, tetanus and whooping cough ...
MM&M

FDA panel push for whooping cough vaccines

A U.S. advisory panel yesterday urged the approval for two new vaccines designed to boost immunity against whooping cough. The panel said the vaccines, GlaxoSmithKline’s Boostrix and Sanofi-Aventis’ ...
Medscape

FDA Approves Expanded Age Indication for Tdap Booster Vaccine

April 20, 2009 — The tetanus toxoid/reduced diphtheria toxoid/acellular pertussis single-dose booster vaccine (Tdap; Boostrix, GlaxoSmithKline Biologicals) was approved for an expanded age indication ...
PharmaTimes

FDA panel backs Boostrix and Adacel vaccines

GlaxoSmithKline and Sanofi-Aventis were celebrating yesterday after a US Food and Drug Administration advisory panel unanimously recommended that the agency approve their rival diphtheria, tetanus and ...